High-throughput screening (HTS) is a common mechanism for identifying lead compounds for drug discovery efforts. Small molecules can inhibit enzymes by a variety of mechanisms, such as competitive, noncompetitive, and uncompetitive with respect to the substrate(s) of the catalytic reaction. To optimize the chances of finding the broadest diversity of inhibitor modalities during screening, one must run assays under ''balanced'' conditions where the potency of inhibitors with various modes of action falls within a similar range. When an enzyme reaction involves more than one substrate, the definition and assessment of the apparent potency of inhibitors (IC 50 ), in relation to their true potency (K i ), can be nontrivial. This article provides a theoretical analysis, on the basis of the Cheng-Prusoff derivation, of the IC 50 /K i relationship of bisubstrate enzyme reactions following various sequential kinetic mechanisms, as well as the application and limitations of this information for defining optimal screening conditions for such enzymes. (Journal of Biomolecular Screening 2009:111-120) 
INTRODUCTION
H IGH-THROUGHPUT SCREENING (HTS) IS COMMONLY USED in pharmaceutical research to identify novel agonists and antagonists (i.e., inhibitors) for targets of interest. Recent surveys reveal that enzyme inhibitors represent a major fraction of all marketed small-molecule drugs. 1, 2 Looking forward, many of the remaining unmet needs in human medicine today can be approached by inhibition of selective enzyme targets. A significant portion of preclinical drug research within the pharmaceutical industry is thus targeted toward identification and pharmacological optimization of enzyme inhibitors. Hence, establishing appropriate enzyme activity assays for HTS is critical for modern drug discovery. A number of reviews have discussed the parameters to be considered in setting up enzyme assays for HTS. 3�8 These parameters include a number of practical considerations, such as signal to background (e.g., the Z 0 statistic), cost per assay, throughput of the assay, and so on. To maximize the opportunity to identify mechanistically diverse inhibitors, one must ensure that the HTS assays are performed under biochemically rigorous conditions. 6 Depending on how they interact with the enzyme targets, inhibitors display different inhibition modalities or modes of action (MOAs, i.e., competitive, noncompetitive, and uncompetitive inhibitors; see Segal, 9 Copeland, 10,11 and Case et al. 12 for definitions of these terms) against individual substrates. In many cases, it is desirable to develop the HTS with the objective of finding inhibitors with a broad spectrum of MOAs. The most fundamental approach to achieve this goal is to carry out detailed kinetic studies to define the population of different enzyme species and to identify conditions that allow a balanced representation of all enzyme species in the screening. 12 This approach, however, requires a significant amount of work and is not always feasible. Another approach is to predict and balance the apparent potency (IC 50 ) of inhibitors of various MOAs under a certain set of assay conditions using steady-state parameters that are generally easier to obtain. This approach is valid because the apparent potency of an inhibitor is directly related to the abundance of the enzyme species it interacts with. During the catalytic reaction, inhibitor and substrate(s) may compete for the binding of various enzyme species. Changes of substrate concentration perturb the steady-state equilibrium of the system and hence affect the apparent potency of the inhibitor. This can be illustrated by considering a 1-substrate reaction. For an enzymatic reaction with a single substrate, the effect of substrate concentration on the apparent potency (IC 50 ) of inhibitors with various modes of inhibition can be described as in Figure 1 , based on equations presented previously. 13 It is clear from this figure that whereas the IC 50 value remains constant for a noncompetitive inhibitor over varying substrate concentrations, it increases dramatically at high or low substrate concentrations for the competitive or uncompetitive inhibitors, respectively. This change in the apparent potency directly reflects the change in the concentration of the inhibited enzyme species at different substrate concentrations. For example, the increase in substrate concentration enriches the ES complex and correspondingly reduces the apparent potency of a competitive inhibitor that targets only the free enzyme (E). It can also be seen that for a 1-substrate reaction, assays set up at a substrate concentration equal to K m provide the best opportunity to identify inhibitors with diverse modes of action. An assay run this way has been described as being under ''balanced'' conditions in which the concentrations of various enzyme species at steady state and, consequently, the IC 50 values of inhibitors with various MOAs fall in a similar range. 6 Although finding balanced assay conditions is relatively straightforward for a 1-substrate enzymatic reaction, the situation is more complex for bisubstrate enzyme systems that are far more frequently encountered in drug discovery. Many target enzymes of pharmacological interest conform to a bi-bi reaction mechanism, in which 2 substrate molecules are transformed into 2 product molecules. The bi-bi enzyme reactions generally can be divided into 3 major classes of reaction mechanisms: rapid equilibrium random mechanism, compulsory ordered mechanism, and ping-pong mechanism. Among those, the 2 sequential mechanisms (rapid equilibrium random and compulsory ordered) are most common. In this article, we present a detailed theoretical analysis of the relationship between the apparent potency (IC 50 ) and the inhibition constant (K i ) of inhibitors with various MOAs for bisubstrate enzyme systems following a sequential kinetic mechanism. On the basis of this analysis, we propose guidelines for establishing balanced assay conditions for HTS to identify inhibitors of diversified inhibition modalities.
GENERAL CONSIDERATIONS
The current work focuses on the 2 most commonly observed sequential mechanisms for the bisubstrate reactions: rapid equilibrium random ( Fig. 2A ) and compulsory ordered ( Fig. 2B) . These 2 mechanisms can be distinguished and the order of substrate addition determined by substrate double titration and product and dead-end inhibition studies. 9 For both kinetic mechanisms, the chemical transformation of substrates occurs after the formation of the ternary complex (EAB). The rate equation for both rapid equilibrium random and compulsory ordered mechanisms (including steady-state ordered and rapid equilibrium ordered) can be described as
where K A m and K B m represent the Michaelis constants for substrate A and B, respectively. K A d is the dissociation constant for A. V max is the maximal reaction velocity.
The factor a can be defined as the ratio of the Michaelis and equilibrium dissociation constants for substrate A.
For the rapid equilibrium random mechanism, a also equals K B m =K B d . Therefore, it describes the effect of one substrate on the binding affinity of the other substrate, with a = 1; a > 1, and a < 1 representing no effect, negative cooperativity, and positive cooperativity, respectively. However, this factor has different physical meanings for the compulsory ordered mechanism. Although an a value can still be generated from data fitting, it has no meaning for substrate B. In this case, a equals the ratio between the reaction turnover number k cat and the dissociation rate constant for substrate A (k −1 ), a = k cat /k −1 . 14 In practice, the apparent K m (K app m ) of one substrate is usually determined at a fixed and nonsaturating concentration of the second substrate. The K app m for A and B at any fixed concentration of the other substrate can be derived from equation (1) (detailed derivation can be found in the appendix): It is clear from equations (3) and (4) that the K app m for A and B is a function of B and A concentrations, respectively. It can be shown using the above equations that both substrates can be set at their K app m concentrations if the following conditions described by equation (5) are met. This equation can be derived directly from equations (3) and (4) 
With these basic concepts in hand, we next examine the rapid equilibrium random and compulsory ordered mechanisms individually under the conditions laid out in this section, for the purpose of defining balanced screening conditions for these systems. There are several assumptions used for this analysis. First, the reaction in the absence of the inhibitor follows Michaelis-Menton kinetics. Second, all inhibitors are reversible, and binding of the inhibitor is fast with no time dependence. Third, for all forms of the enzyme that bind a particular inhibitor, it is assumed that the affinity of the inhibitor for all of these enzymes forms is equivalent or at least of similar magnitude. This assumption is made for practical reasons because no uniform solutions can be derived if the binding affinities vary significantly for a specific inhibitor toward different enzyme species.
RAPID EQUILIBRIUM RANDOM SEQUENTIAL MECHANISM
In this mechanism, substrate binding and product release follow a random order. The following analysis is focused on inhibition MOAs versus substrate A. Because the schemes are symmetrical, different mode of actions with regard to substrate B can be derived and analyzed in the same manner and are omitted from the following description.
A competitive inhibitor versus A is able to bind both E and EB forms of the enzyme. Assuming that the inhibitor binds to both forms with roughly equal affinity (K i ), the following equation can be derived for IC 50 expression (details of this and the following derivations are presented in the appendix):
For a noncompetitive inhibitor that binds to E, EA, EB, and EAB equally, it can be seen that its apparent potency equals its true potency K i :
If the inhibitor follows an uncompetitive pattern that binds to EA and EAB forms of the enzyme, the following equation can be derived for the IC 50 expression, assuming that the inhibitor binds to both forms with roughly equal affinity:
It is clear that for a rapid equilibrium random reaction that meets all the assumptions described above, the IC 50 /K i relationship takes the same form as those of the 1-substrate reactions ( Fig. 1) . The difference lies in the K m term. Whereas the true K m is used in equations describing the single substrate reactions, the K app m is used for the bisubstrate reactions. Therefore, the balanced condition with regard to substrate A is achieved when [A] = K A, app m because under this condition, inhibitors with all MOAs against substrate A display an apparent potency (IC 50 ) close to the true K i , and the assay condition is not biased toward any particular MOA. Similarly, the balanced conditions with regard to substrate B are achieved when [B] = K B, app m . Therefore, overall balanced conditions are achieved when both substrates are at their respective K app m concentrations (equation (5)) for reactions that follow the rapid equilibrium random mechanism.
COMPULSORY ORDERED SEQUENTIAL MECHANISM
For the compulsory ordered sequential mechanism ( Fig. 2B) , substrate A must bind to the enzyme prior to substrate B. The reaction proceeds to product formation only after the ternary complex (EAB) is formed.
For a noncompetitive inhibitor versus substrate A or B that binds to E, EA, and EAB equally, the IC 50 is defined by equation (9) (details of this and the following derivations are presented in the appendix). (9) can be reduced to equation (10) . It is clear from this equation that under this condition, the IC 50 value lies between K i and 2K i , regardless of the value of the factor a.
Next, we analyze the inhibition MOA versus substrate A and B separately.
MOA versus substrate A
A competitive inhibitor versus A is able to bind only the free enzyme form (E). The relationship between IC 50 and K i for such an inhibitor is defined by equation (11).
Note that equation (11) 
It can be seen from equation (12) that increases in the concentration of the second substrate (B) decrease the apparent potency of an A competitive inhibitor in this mechanism. It is therefore desirable to screen at low B concentrations if A competitive inhibitors are the primary target of the screening. An increase in a also results in higher IC 50 values. This is because for the ordered mechanism, higher a is associated with a decrease in the dissociation constant for substrate A relative to k cat . Therefore, high a represents an increased relative proportion of species EA and hence a higher IC 50 for A competitive inhibitors.
When both A and B concentrations are set to be equal to their respective K app m values, equation (11) can be further simplified to equation (13):
If the inhibitor follows an uncompetitive pattern versus substrate A and binds to EA and EAB forms of the enzyme with equal affinity, the equation describing the relationship between IC 50 and K i takes the form of the Cheng-Prusoff equation for a single substrate reaction:
MOA versus substrate B
Next, we examined the different inhibition patterns versus substrate B. Competitive inhibitors versus B, by definition, are able to bind both the free enzyme (E) and the EA form. The following equation can be derived for the IC 50 expression for such an inhibitor if it binds E and EA with equal affinity:
Uncompetitive inhibitors versus substrate B are expected to bind to only the EAB ternary form of the enzyme. Equation (16) can be derived for this type of inhibition as described previously. 13 In this equation, V 0 represents the initial velocity at the substrate concentrations used in the assay. Therefore, higher A and/or B concentrations increase the apparent potency of B uncompetitive inhibitors under this condition.
When both A and B concentrations are set to be equal to their respective K app m , equation (16) can be simplified to equation (17). Note that this equation takes the identical form as equation (13) .
Balanced conditions for compulsory ordered mechanism , and a on the ratio of IC 50 /K i for inhibitors of various MOAs for bisubstrate reactions following a compulsory ordered mechanism with A binding first. It can be seen from Figures 3A and 4A that at a constant a, increases in [A] and [B] result in an increase in the IC 50 /K i ratio for A and B competitive inhibitors, respectively. This is a predicted pattern for competitive inhibition. However, the effect of the other substrate is different. Higher [B] induces a more significant increase in IC 50 /K i for A competitive inhibitors (Fig. 3A) . Therefore, for a compulsory ordered reaction with A binding first, it is desirable to run at low B concentrations when screening for A competitive inhibitors. On the other hand, for B competitive inhibitors, although the effect of [A] is marginal when a < 1, lower [A] induces higher IC 50 /K i ratios when a > 1 (Fig. 6A) . For both A and B competitive inhibitors, higher a increases the IC 50 /K i ratio ( Figs. 5A and 6A) .
Increases in [A] and [B]
lead to an initial drop in IC 50 /K i followed by a plateau level for uncompetitive inhibitors of A and B, respectively ( Figs. 3B and 4B) . For uncompetitive inhibitors versus A, the effect of a as well as [B] on IC 50 /K i is marginal unless a is significantly less than 1 (Fig. 5B) . For example, when a ∼ 0:1, decreasing a and/or [B] results in a sharp increase in IC 50 /K i . For uncompetitive inhibitors versus B, the effect of a and [A] is more significant, and lower a and/or [A] lead to higher IC 50 /K i ratios (Fig. 6B) .
For noncompetitive inhibition, the change of IC 50 /K i is generally not significant upon changes in substrate concentration FIG. 3 . Effect of substrate concentrations on the apparent potency (IC 50 /K i ) of (A) competitive, (B) uncompetitive, and (C) noncompetitive inhibitors versus substrate A for reactions following a compulsory ordered mechanism. The simulation was carried out with K A m = K B m = 10, a = 1, and [B] = 50, 10, and 2. Varying the a value does not affect the trend of the IC 50 /K i ratios observed in this simulation for various modes of action (MOAs).
[B] has no effect on the IC 50 /K i ratio for uncompetitive inhibitors versus substrate A under this condition (a = 1), although it does have an effect when a is not equal to 1.
FIG. 4.
Effect of substrate concentrations on the apparent potency (IC 50 /K i ) of (A) competitive and (B) uncompetitive inhibitors versus substrate B for reactions following a compulsory ordered mechanism. The simulation was carried out with K A m = K B m = 10, a = 1, and [A] = 50, 10, and 2. Varying the a value does not affect the trend of the IC 50 /K i ratios observed in this simulation for various modes of action (MOAs). The apparent potency of noncompetitive inhibitors versus B follows the same trend as depicted in Figure 3C. [A] has no effect on the IC 50 /K i ratio for competitive inhibitors versus substrate B under this condition (a = 1), although it does have an effect when a is not equal to 1. and/or a (Figs. 3C and 5C ). This is also evident in equation (9) because under most conditions, the numerator of the second term in parentheses is smaller than the denominator.
In several cases for the ordered mechanism, the relationship between IC 50 and K i cannot be described by using a simple parameter such as K app m . Instead, the true K m values, the substrate concentrations, and the a factor are all required for a quantitative evaluation. These factors affect the apparent potency of inhibitors quite differently when they follow different MOAs. For example, higher a generally induces lower IC 50 /K i for uncompetitive inhibition but higher IC 50 /K i for competitive inhibition. And whereas lower [B] is beneficial Figure 5C .
for screening competitive inhibitors versus A, higher [A]
should be used when the screening is targeting uncompetitive and/or competitive inhibitors versus B. Therefore, there is not a single screening condition that is optimal for all inhibition MOAs under all conditions. However, a near-optimal condition can be achieved when both [A] and [B] are at their K app m values as long as a is not significantly greater than 1. As stated previously, this is also the balanced screening condition for bisubstrate reactions following a rapid equilibrium random mechanism. As seen in Table 1 , for reactions following an ordered mechanism, the IC 50 shift is generally less than 4-fold under this condition when a is close to 1. However, although lower a values do not present an issue, this condition increasingly deviates from the balanced condition as a increases. The overall shift in the apparent potency is close to 10-fold when a = 10 for A competitive and B uncompetitive inhibitors, whereas for other MOAs, the shift remains around 2-fold. Therefore, when a is significantly greater than 1, this K app m condition may no longer be balanced, and the optimal condition can be determined by a simulation study using equations (9) to (17).
DISCUSSION
In this work, a detailed analysis was carried out to examine the relationship between the apparent potency (IC 50 ) and the intrinsic potency (K i ) of inhibitors for bisubstrate reactions based on the methods developed by Cheng and Prusoff. The purpose of this work is to guide the selection of appropriate substrate concentrations to achieve balanced conditions for screening inhibitors of various MOAs. The balanced screening conditions for a single substrate reaction are typically achieved by setting the substrate concentration at its K m under which both E and ES are present with similar abundance at steady state. 6, 10, 12 However, for bisubstrate systems, the K m of each substrate is affected by the degree of saturation of the other substrate, and this effect is different for reactions following different kinetic mechanisms. 9 In this report, we examined the effect of substrate concentrations on the abundance of various enzyme species and hence the apparent potency (IC 50 ) of inhibitors for bisubstrate reactions, thus defining ''balanced'' enzyme assay conditions in a practical manner. Our methodology can be used to guide the selection of appropriate substrate concentrations to achieve balanced conditions for screening inhibitors of various MOAs.
To understand the relationship between the apparent potency (IC 50 ) and the intrinsic potency (K i ) of inhibitors for bisubstrate reactions, we took advantage of the methods developed by Cheng and Prusoff 13 and extended their analysis to describe additional possibilities for inhibitors of bi-bi reactions that follow sequential kinetic mechanisms. Of the 8 scenarios we considered, many were not discussed by Cheng and Prusoff, and several scenarios presented here are different from what Cheng and Prusoff have described for bi-bi reactions. 13 For example, Cheng and Prusoff derived equations for inhibitors that only bind to the free enzyme yet compete for the binding of A or B in a random mechanism. For our derivation, we considered that an A competitive inhibitor in a random mechanism is most likely able to bind to both the free enzyme (E) and the enzyme form with B bound (EB). We derived equation (6) to describe this possibility. In the current work, we further simplified equations by substituting the intrinsic K m and K d terms with the K app m parameter wherever possible. This greatly facilitates the practical analysis.
Using the IC 50 versus K i relationship derived for inhibitors with different MOAs, we examined the effect of substrate concentrations on the abundance of various enzyme species and hence the apparent potency of inhibitors for bisubstrate reactions. This analysis showed that for reactions following a rapid equilibrium random mechanism, balanced assay conditions can be achieved when both substrates are at their respective K app m concentrations. Equations for generating a unique set of A and B concentrations where both are at their K app m were presented. For reactions following a compulsory ordered mechanism, the advantage of using this condition is that the IC 50 shift depends solely on the a factor. We showed that this condition works reasonably well as long as the a factor is below a certain cutoff value. The choice of the cutoff value for a is determined by individual assay conditions. For example, if the assay sensitivity and the inhibitor titration scheme would allow the identification of inhibitors with a 10-fold up-shift of the IC 50 , then a = 10 could be used as the cutoff value for the system (Table 1) . When a is above the cutoff value, simply setting both substrate concentrations at their K app m will not achieve the desired balanced condition. In this case, information about the order of substrate binding is necessary to determine the optimal conditions for the screening.
Under some circumstances, this situation may be simplified because one may only be concerned with finding inhibitors of different MOAs toward one of the substrates. Some assay methods may also limit the concentration for a specific substrate in a bisubstrate system. For example, the HTRF (homogeneous time-resolved fluorescence) method to assay tyrosine kinase activity is severely restricted in the range of peptide substrate concentration that can be tolerated. This can be advantageous for a compulsory ordered reaction with adenosine triphosphate (ATP) binding first because low peptide concentrations help to increase the apparent potency of ATP-competitive inhibitors.
In general, we recommend the following procedure for defining balanced screening conditions. First, a substrate double-titration experiment should be carried out to determine the K m values for both substrates and the factor a. 9, 11 Different approaches may then be employed depending on the magnitude of a. If a is close to 1 and below a certain cutoff value, the screening can be performed under conditions where both substrate concentrations are set at their respective K app m values as defined by equation (5) . If a is greater than the cutoff value, then the kinetic mechanism needs to be determined and a simulation study carried out with the right set of equations for the specific mechanism to define the conditions under which inhibitors with various MOAs can be uncovered.
The treatments described here provide a rational mechanism for determining optimal screening assay conditions with respect to substrate concentrations for enzymes that conform to a sequential bisubstrate reaction mechanism. These treatments should prove useful to scientists engaged in screening activities aimed at identifying inhibitors of various MOAs against a broad spectrum of enzyme targets. Eq. 4 in the main text can be derived similarly.
Derivation of relationship between IC 50 and K i for inhibitors of different MOAs
Rapid equilibrium random mechanism For competitive inhibitors versus A that bind to E and EB with equal affinity (K i ), the rate equation can be written as: 
